Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.750
+0.020 (0.54%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Adagene Market Cap
Adagene has a market cap or net worth of $247.77 million as of July 31, 2026. Its market cap has increased by 161.67% in one year.
Market Cap
247.77M
Enterprise Value
178.19M
1-Year Change
161.67%
Ranking
Category
Stock Price
$3.75
ChartMarket Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $247.77M, a decrease of -69.19%. That is a compound annual growth rate of -19.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 247.77M | 178.15% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 265.97M |
| Eledon Pharmaceuticals | 261.28M |
| ALX Oncology Holdings | 261.05M |
| Surrozen | 257.87M |
| Anavex Life Sciences | 254.85M |
| InflaRx | 250.40M |
| Turn Therapeutics | 249.03M |
| Entrada Therapeutics | 244.67M |